TAG opposes the DCR reorganization until the public is provided with sufficient information about the proposed changes to comment on the potential implications.
This article, Infections Post-inequalities: Realizing the End of Tuberculosis Through Equitable Economic Orders, explores TB as a proxy metric for the failure to dismantle colonial structures in global health and to realize the rights to health and science. Fundamentally, the…
Ending HIV requires sustained research. TAG’s cure trials updates tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.
Contact: adam.ortega@treatmentactiongroup.org New York, September 4, 2026 – Treatment Action Group (TAG) calls for immediate provision of tuberculosis (TB) prevention and care, access to robust healthcare services, and healthy living conditions for all those held in detention by the U.S…
Contact: Teju Dharmapuri Vachaspathi, teju.dv@treatmentactiongroup.org August 20, 2026 — Treatment Action Group (TAG) welcomes the access price for PlusLife MiniDock MTB near point-of-care (NPOC) tuberculosis (TB) tests, now newly available for $2.60 per test. PlusLife MiniDock MTB is the first…
This suite of materials is designed to build community treatment literacy on the side effects of medications used to treat DR-TB and to support community engagement in active drug safety monitoring and management (ADSM) initiatives.
In September, TAG hosted a free movie screening of "How to Survive a Plague" followed by an activist panel at the Housing Works Bookstore. David France's documentary "How to Survive a Plague" tells the story of how AIDS activists taught…
Treatment Action Group (TAG) calls for recognition of Dr. Anthony S. Fauci as a public health hero who has helped lead the global research and public health responses to multiple pandemics including HIV/AIDS, SARS, Ebola, MERS, Zika, and SARS-Cov-2/COVID, and joins the chorus of outrage directed at the Republican U.S. senators pursuing an ignorant and dishonest persecution of the former Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH).
On Aug. 19 & 20, TAG is hosting a two-part webinar covering WHO guideline updates for pre-extensively drug-resistant TB and approaches to addressing additional bedaquiline-resistance (extensively drug-resistant TB).
Read TAG's 2025 Annual Report. Check out some of our biggest wins and how we fought for the public's health in 2025. We couldn't do this work without your support.
The Research in Action Awards are on Thursday, October 15 from 6-9 p.m. at The Angel Orensanz Foundation, 172 Norfolk St., in the Lower East Side. TAG’s premier fundraising event honors the brightest scientists, activists, and artists working to end HIV, TB, and HCV.
Learn more and buy tickets now!
